[Low-dose rituximab regimen in 7 patients with immune thrombocytopenia secondary to connective tissue disease]

Related Experiment Video

Updated: May 15, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Hong-Mei Wang, Yan-Hui Yang, Min Xuan

    Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
    |January 23, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
    10:58

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

    Published on: March 5, 2019

    Related Experiment Videos

    Last Updated: May 15, 2026

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
    10:58

    Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

    Published on: March 5, 2019

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

    Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

    Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Multimodal Artificial Intelligence System for Risk-Adapted Cancer Survivorship Surveillance: A Multicenter Target Trial Emulation.

    International journal of radiation oncology, biology, physics·2026

    Pyroptosis-associated inflammasome activation contributes to scleral remodeling in experimental myopia.

    International journal of ophthalmology·2026

    Pediatric candidemia epidemiology and antifungal susceptibility profiles reported by the ISPED program in China, 2016-2024.

    Antimicrobial agents and chemotherapy·2026

    [Soil Microbial Nutrient Limitation Characteristics During Anthropogenic Transition from Desert Steppe to Shrubland].

    Huan jing ke xue= Huanjing kexue·2026

    Mechanistic insights from experimental autoimmune encephalomyelitis into immune regulation, autophagy, gut microbiota, blood-brain barrier integrity, and NLRP3 inflammasome-mediated pyroptosis in multiple sclerosis: potential clinical implications.

    Frontiers in neuroscience·2026

    Phylogenetic Comparison and Splice Site Conservation of the Animal SMNDC1 Gene Family.

    Genesis (New York, N.Y. : 2000)·2026

    [The risk and management strategies for second primary tumor after CAR-T cell therapy].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    [From structure to function: new developments in the interaction of coagulation factor Ⅴ with tissue factor pathway inhibitor α].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    [KMT2A-rearranged acute lymphoblastic leukemia with lineage switch following relapse: a case report and literature review].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    [Whole blood exchange for a critically ill patient with Hodgkin lymphoma complicated by severe autoimmune hemolytic anemia: a case report and literature review].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    [Impact of non-donor specific HLA antibodies on outcomes of allogeneic hematopoietic stem cell transplantation].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    [Clinical analysis of nine pediatric cases of acute myeloid leukemia with NUP98 rearrangement].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026

    Scleroderma-Like Phenotype in a Patient With Transthyretin Cardiac Amyloidosis and Acromegaly: A Triple Diagnostic Challenge.

    Cureus·2026

    In-vitro exposure to mercury chloride, with and without n-3 long chain polyunsaturated fatty acids, on the Th17-associated immune response in peripheral blood mononuclear cells from systemic lupus erythematosus patients.

    Journal of immunotoxicology·2026

    Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Harnessing Immunological Properties.

    Biomolecules & therapeutics·2026

    Molecular underpinnings of rheumatic diseases and emerging therapeutic concepts.

    Nature·2026

    Adaptive immune plasticity in MASH: Functional states, pathological consequences, and regulatory mechanisms.

    Hepatology communications·2026

    Imaging of myositis: An overview and update.

    Seminars in nuclear medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us